Skip to main content

Gohibic Injection Dosage

Generic name: vilobelimab 10mg in 1mL
Dosage form: injection
Drug class: Miscellaneous antivirals

Medically reviewed by Drugs.com. Last updated on May 16, 2023.

Recommended Dosage

The recommended dosage of GOHIBIC for the treatment of adults with COVID-19 is 800 mg administered by intravenous infusion after dilution [see Dosage and Administration (2.2)] for a maximum of 6 (six) doses over the treatment period as described below.

Treatment should be started within 48 hours of intubation (Day 1) followed by administration on Days 2, 4, 8, 15 and 22 as long as the patient is hospitalized (even if discharged from ICU).

Preparation and Administration

Preparation

Using aseptic technique, dilute and prepare GOHIBIC for intravenous infusion before administration.

  • For the recommended dose of 800 mg GOHIBIC, dilute 80 mL of GOHIBIC in 170 mL of 0.9% Sodium Chloride at room temperature.
  • Use a 250 mL infusion bag of 0.9% Sodium Chloride solution USP and the follow steps below:
    • Withdraw 80 mL of 0.9% Sodium Chloride solution USP from the infusion bag and discard.
    • Withdraw the 80 mL of GOHIBIC from the vials and add slowly to the 0.9% Sodium Chloride solution USP infusion bag to a final concentration of 3.2 mg/mL.
    • To mix the solution, gently invert the bag to avoid foaming.

Storage of Diluted GOHIBIC

  • Diluted GOHIBIC must be used within 4 hours when stored at room temperature 20°C to 25°C (68°F to 77°F).
  • Diluted GOHIBIC stored under refrigeration at 2°C to 8°C (36°F to 46°F) must be used within 24 hours.
  • After removal of diluted GOHIBIC from the refrigerator stored at 2°C to 8°C (36°F to 46°F), it must be left to acclimatize to room temperature prior to administration.

Administration

  • Visually inspect for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if discoloration or visible particles are present.
  • Administer diluted GOHIBIC via intravenous infusion over 30 - 60 minutes.
  • Avoid concomitant administration of GOHIBIC with other drugs in the same intravenous line.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.